JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1994; 23:377-383
© 1994 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ley, C.
Right arrow Articles by Stevenson, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ley, C.
Right arrow Articles by Stevenson, J.

Insulin resistance, lipoproteins, body fat and hemostasis in nonobese men with angina and a normal or abnormal coronary angiogram

CJ Ley, J Swan, IF Godsland, C Walton, D Crook, and JC Stevenson

Wynn Institute for Metabolic Research, London, England, United Kingdom.

OBJECTIVES. The aim of this study was to compare metabolic risk factors in men with anginal chest pain and a normal or abnormal coronary angiogram with those in healthy men. BACKGROUND. Risk factors for coronary heart disease, including lipoprotein abnormalities, hypertension and adiposity, may be metabolically interlinked, with insulin resistance and hyperinsulinemia being pivotal to these disturbances. METHODS. Glucose and insulin metabolism, lipids and lipoproteins, hemostasis, blood pressure and body fat distribution were measured in 77 nonobese middle-aged men who had anginal chest pain (39 with an abnormal coronary angiogram and 38 with no detectable angiographic abnormality) and were compared with those of 40 healthy men of similar age and body mass index. RESULTS. Patients with chest pain had higher insulin responses to an intravenous glucose challenge, lower insulin sensitivity, lower high density lipoprotein (HDL) and subfraction 2 cholesterol, lower apolipoprotein AI, higher triglycerides, greater android fat and higher systolic blood pressure at rest compared with levels in healthy control subjects (p < 0.05). Those with an abnormal coronary angiogram had lower tissue plasminogen activator levels, higher plasminogen activator inhibitor 1 levels and more android fat than did those with a normal angiogram (p < 0.05). Insulin sensitivity correlated positively with HDL (p < 0.05) and subfraction 2 (p < 0.001) cholesterol and negatively with triglycerides (p < 0.01), android fat proportion (p < 0.01) and systolic blood pressure (p < 0.05), whereas insulin response showed converse correlations. CONCLUSIONS. These findings provide new evidence of the central role of insulin resistance and hyperinsulinemia in the development of risk factors associated with coronary heart disease.


This article has been cited by other articles:


Home page
Clin. Chem.Home page
J. Frohlich and M. Dobiasova
Fractional Esterification Rate of Cholesterol and Ratio of Triglycerides to HDL-Cholesterol Are Powerful Predictors of Positive Findings on Coronary Angiography
Clin. Chem., November 1, 2003; 49(11): 1873 - 1880.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
S. Takata, A. Shimakura, S. Sakagami, Y. Nakamura, H. Ohkuwa, K.-i. Kobayashi, and H. Nagai
Enhanced Insulin Response to Oral Glucose Load in Patients with Angina Pectoris Associated with ST Segment Elevation in the Absence of Epicardial Coronary Arterial Obstruction
Angiology, September 1, 1998; 49(9): 815 - 826.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. Toft, K. H. Bonaa, O. C. Ingebretsen, A. Nordoy, and T. Jenssen
Fibrinolytic Function After Dietary Supplementation With {omega}3 Polyunsaturated Fatty Acids
Arterioscler. Thromb. Vasc. Biol., May 1, 1997; 17(5): 814 - 819.
[Abstract] [Full Text]


Home page
CirculationHome page
T. K. Nordt, K. Kornas, K. Peter, S. Fujii, B. E. Sobel, W. Kubler, and C. Bode
Attenuation by Gemfibrozil of Expression of Plasminogen Activator Inhibitor Type 1 Induced by Insulin and its Precursors
Circulation, February 4, 1997; 95(3): 677 - 683.
[Abstract] [Full Text]


Home page
CirculationHome page
H. Taegtmeyer
Insulin Resistance and Atherosclerosis : Common Roots for Two Common Diseases?
Circulation, May 15, 1996; 93(10): 1777 - 1779.
[Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1994 by the American College of Cardiology Foundation.